Thus, the data suggest that AR agonist‐ or antagonist‐treated PCa cells are resistant to lymphocyte‐mediated apoptosis with agonist exhibiting a stronger resistance compared to ENZ treatment. The gene discussed is AR; the disease is posterior cortical atrophy.